These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11108)

  • 1. Centrally induced reduction in sympathetic tone-a postsynaptic alpha-adrenoceptor-stimulating action of imidazolines.
    Kobinger W; Pichler L
    Eur J Pharmacol; 1976 Dec; 40(2):311-20. PubMed ID: 11108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of clonidine on responses to sympathetic nerve stimulation in the pithed rat.
    Doxey JC; Everitt J
    Br J Pharmacol; 1977 Dec; 61(4):559-66. PubMed ID: 23192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonidine-induced inhibition of sympathetic nerve activity: no indication for a central presynaptic or an indirect sympathomimetic mode of action.
    Haeusler G
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 286(1):07-111. PubMed ID: 4281069
    [No Abstract]   [Full Text] [Related]  

  • 4. Investigation into some imidazoline compounds, with respect to peripheral alpha-adrenoceptor stimulation and depression of cardiovascular centers.
    Kobinger W; Pichler L
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 291(2):175-91. PubMed ID: 628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that some imidazoline derivatives inhibit peripherally the vasopressor sympathetic outflow in pithed rats.
    Monroy-Ordoñez EB; Villalón CM; Cobos-Puc LE; Márquez-Conde JA; Sánchez-López A; Centurión D
    Auton Neurosci; 2008 Dec; 143(1-2):40-5. PubMed ID: 18774761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reserpine-resistant responses to nerve stimulation in the cat nictitating membrane involve the release of newly synthesized noradrenaline.
    Duval N; Hicks PE; Langer SZ
    Eur J Pharmacol; 1986 Mar; 122(1):93-101. PubMed ID: 2869963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral alpha 2-adrenoceptor-mediated sympathoinhibitory effects of mivazerol.
    Richer C; Gobert J; Noyer M; Wülfert E; Giudicelli JF
    Fundam Clin Pharmacol; 1996; 10(6):529-37. PubMed ID: 8985723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that different regional sympathetic outflows vary in their sensitivity to the sympathoinhibitory actions of putative 5-HT1A and alpha 2-adrenoceptor agonists in anaesthetized cats.
    Ramage AG; Wilkinson SJ
    Br J Pharmacol; 1989 Dec; 98(4):1157-64. PubMed ID: 2575414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular effects of B-HT 958, an alpha-adrenoceptor agonist with a high pre/postsynaptic activity ratio.
    Kobinger W; Pichler L
    Eur J Pharmacol; 1984 Jan; 97(1-2):67-73. PubMed ID: 6141948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proceedings: Sympathetic nerve activity after noradrenaline depletion and its alteration by clonidine.
    Haeusler G
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R29. PubMed ID: 4276555
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacological actions of the antihypertensive agent N-amidino-2-(2,6-dichlorophenyl)acetamide hydrochloride (BS 100-141).
    Scholtysik G; Lauener H; Eichenberger E; Bürki H; Salzmann R; Müller-Schweinitzer E; Waite R
    Arzneimittelforschung; 1975 Oct; 25(10):1483-91. PubMed ID: 1243025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of the sympathoinhibition produced by the clonidine-like drugs rilmenidine and moxonidine.
    Szabo B; Bock C; Nordheim U; Niederhoffer N
    Ann N Y Acad Sci; 1999 Jun; 881():253-64. PubMed ID: 10415923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional and biochemical evidence for the lack of cardiac presynaptic alpha-2 adrenoceptor stimulant properties of cirazoline (LD 3098), a potent alpha-1 adrenoceptor agonist in dogs and rats.
    Cavero I; Lefèvre-Borg F; Roach AG; Gomeni R; Scatton B
    J Pharmacol Exp Ther; 1982 Oct; 223(1):241-50. PubMed ID: 6126583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on the mechanism of action of clonidine after pretreatment with reserpine (author's transl)].
    Tauberger G; Thoneick HU; Dülme HJ
    Arzneimittelforschung; 1978; 28(4):651-4. PubMed ID: 581942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual effect of agmatine in the bisected rat vas deferens.
    Santos WC; Smaili SS; Jurkiewicz A; Piçarro I; Garcez-do-Carmo L
    J Pharm Pharmacol; 2003 Mar; 55(3):373-80. PubMed ID: 12724044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterisation of the presynaptic alpha-adrenoceptor in the rat vas deferens.
    Drew GM
    Eur J Pharmacol; 1977 Mar; 42(2):123-30. PubMed ID: 14838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of the reversal by different alpha 2-adrenoceptor antagonists of the central sympatho-inhibitory effect of clonidine.
    Vayssettes-Courchay C; Bouysset F; Cordi AA; Laubie M; Verbeuren TJ
    Br J Pharmacol; 1996 Feb; 117(3):587-593. PubMed ID: 8821553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced alpha2A-autoreceptor reserve for clonidine induced by reserpine and cholinomimetic agents in the rat vas deferens.
    Pineda J; Ugedo L; García-Sevilla JA
    Br J Pharmacol; 1997 Nov; 122(5):833-40. PubMed ID: 9384498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155). I. Peripheral sympathetic system.
    Boissier JR; Giudicelli JF; Fichelle J; Schmitt H; Schmitt H
    Eur J Pharmacol; 1968 Mar; 2(5):333-9. PubMed ID: 5663498
    [No Abstract]   [Full Text] [Related]  

  • 20. Receptor interactions of imidazolines: alpha-adrenoceptors of rat and rabbit aortae differentiated by relative potencies, affinities and efficacies of imidazoline agonists.
    Ruffolo RR; Waddell JE
    Br J Pharmacol; 1982 Sep; 77(1):169-76. PubMed ID: 6289955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.